Plain-English translation of NCT05885724 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying biological markers in the blood of people with anorexia nervosa to understand the disease at a deeper level and find new ways to treat it. This study will compare blood samples and body composition measurements between adults with anorexia nervosa and healthy volunteers to identify proteins and immune factors that might be targeted by future treatments. The goal is to show that anorexia nervosa is a biological disease, not just something someone can control through willpower alone.
Anorexia nervosa is a serious eating disorder, but current treatments don't work well enough for many people. By identifying specific biological markers that drive the disease, researchers hope to develop more targeted, personalized treatments that go beyond traditional psychiatric care.
You likely qualify if…
You likely don't qualify if…
You will visit the research center where staff will draw blood samples to measure specific proteins and immune markers. You will also have body composition scans (DEXA) and a test to measure how your body uses energy. The study involves approximately 32 participants total — some with anorexia nervosa and some healthy volunteers matched by age and sex — and the visits are designed to take a few hours.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Switzerland
Sponsor
University Hospital, Basel, Switzerland
Collaborators
University of Zurich
Enrollment target
~32 participants
Started
May 2023
Primary completion
April 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 60 Years
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Katharina Timper, Prof.
University Hospital, Basel, Switzerland
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.